IBDEI0BU ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5610,0)
 ;;=196.3^^41^488^99
 ;;^UTILITY(U,$J,358.3,5610,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5610,1,4,0)
 ;;=4^196.3
 ;;^UTILITY(U,$J,358.3,5610,1,5,0)
 ;;=5^Mets to Lymph Nodes,Axillary Or Brachial
 ;;^UTILITY(U,$J,358.3,5610,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,5611,0)
 ;;=196.0^^41^488^100
 ;;^UTILITY(U,$J,358.3,5611,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5611,1,4,0)
 ;;=4^196.0
 ;;^UTILITY(U,$J,358.3,5611,1,5,0)
 ;;=5^Mets to Lymph Nodes,Cervical
 ;;^UTILITY(U,$J,358.3,5611,2)
 ;;=Lymph Nodes^267314
 ;;^UTILITY(U,$J,358.3,5612,0)
 ;;=196.1^^41^488^101
 ;;^UTILITY(U,$J,358.3,5612,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5612,1,4,0)
 ;;=4^196.1
 ;;^UTILITY(U,$J,358.3,5612,1,5,0)
 ;;=5^Mets to Lymph Nodes,Mediastinal 
 ;;^UTILITY(U,$J,358.3,5612,2)
 ;;=Lymph Nodes^267315
 ;;^UTILITY(U,$J,358.3,5613,0)
 ;;=196.8^^41^488^102
 ;;^UTILITY(U,$J,358.3,5613,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5613,1,4,0)
 ;;=4^196.8
 ;;^UTILITY(U,$J,358.3,5613,1,5,0)
 ;;=5^Mets to Lymph Nodes,Multiple Sites
 ;;^UTILITY(U,$J,358.3,5613,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,5614,0)
 ;;=V10.51^^41^488^56
 ;;^UTILITY(U,$J,358.3,5614,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5614,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,5614,1,5,0)
 ;;=5^H/O Bladder Cancer
 ;;^UTILITY(U,$J,358.3,5614,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,5615,0)
 ;;=V10.3^^41^488^57
 ;;^UTILITY(U,$J,358.3,5615,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5615,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,5615,1,5,0)
 ;;=5^H/O Breast Cancer
 ;;^UTILITY(U,$J,358.3,5615,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,5616,0)
 ;;=V10.41^^41^488^58
 ;;^UTILITY(U,$J,358.3,5616,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5616,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,5616,1,5,0)
 ;;=5^H/O Cervical Cancer
 ;;^UTILITY(U,$J,358.3,5616,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,5617,0)
 ;;=V10.05^^41^488^59
 ;;^UTILITY(U,$J,358.3,5617,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5617,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,5617,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,5617,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,5618,0)
 ;;=V10.03^^41^488^60
 ;;^UTILITY(U,$J,358.3,5618,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5618,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,5618,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,5618,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,5619,0)
 ;;=V10.60^^41^488^62
 ;;^UTILITY(U,$J,358.3,5619,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5619,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,5619,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,5619,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,5620,0)
 ;;=V10.11^^41^488^63
 ;;^UTILITY(U,$J,358.3,5620,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5620,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,5620,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,5620,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,5621,0)
 ;;=V10.79^^41^488^64
 ;;^UTILITY(U,$J,358.3,5621,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5621,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,5621,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,5621,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,5622,0)
 ;;=V10.82^^41^488^65
 ;;^UTILITY(U,$J,358.3,5622,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5622,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,5622,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,5622,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,5623,0)
 ;;=V10.02^^41^488^68
 ;;^UTILITY(U,$J,358.3,5623,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5623,1,4,0)
 ;;=4^V10.02
